Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk

Abstract

Hsp70 induction is a novel approach to delay thrombus formation with minimal bleeding risk, and is especially promising for treating AF patients and in other situations where there is also a major bleeding hazard.